Want to join the conversation?
Biopharmaceutical company $REGN posted almost flat 2Q16 results. $REGN said net income rose 0.51% to $196MM, or $1.69 per share from $195MM, or $1.69 per share a year ago. Total revenues rose 21.42% to $1.21Bil versus a year ago, helped by inclusion of Sanofi and Bayer collaboration revenues. Excluding items $REGN earned $2.82 per share.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.